Status:
RECRUITING
Management of Sleeve Gastrectomy Failure Using Single-anastomosis Metabolic Surgery
Lead Sponsor:
Laval University
Collaborating Sponsors:
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Conditions:
Obesity
Obesity, Morbid
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Sleeve gastrectomy (SG) has become the most commonly performed weight loss surgery, accounting for 60% of all bariatric operations worldwide. While technically easier with less side-effects and nutrit...
Eligibility Criteria
Inclusion
- had sleeve gastrectomy a minimum of 18 months before
- still meet the NIH criteria for bariatric surgery (BMI≥35kg/m2 with major comorbidities or BMI≥40kg/m2) or patients with EWL\<50% or significant weight regain (≥20%EWL)
Exclusion
- general contra-indication for bariatric surgery
- BMI\<35kg/m2
- pregnancy
- cirrhosis
- abnormal bowel habits including irritable bowel syndrome and inflammatory bowel disease
Key Trial Info
Start Date :
February 3 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2027
Estimated Enrollment :
151 Patients enrolled
Trial Details
Trial ID
NCT05242835
Start Date
February 3 2023
End Date
March 1 2027
Last Update
December 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Universitaire de Cardiologie et de Pneumologie de Québec
Québec, Quebec, Canada, G1V 4G5